Galecto Biotech (private company)

See something wrong or missing? Let us know
Offices:
Copenhagen
Business model:
B2B
Investors:
we tracked 11 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 4 transactions

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

M&A and Exit deals (USD) - we tracked 1 transaction

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Galecto Biotech AB develops galectin modulators for the treatment of severe diseases, including fibrosis, cancer and inflammation

Companies with similar profile to Galecto Biotech:

CompanyCriteria
Denmark STipe Therapeutics
76%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • At least one other investor: Novo A/S
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark AFYX Therapeutics
66%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark NMD Pharma
66%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Germany Tubulis
66%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Seventure Partners
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Norway Oncoinvent
66%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Hadean Ventures
  • At least one other investor: Canica AS
  • Total raised in a similar range: 10M+ USD
Denmark Draupnir Bio
66%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Orphazyme
65%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • At least one other investor: Novo A/S
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Forendo Pharma
65%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures, Novo Seeds
  • At least one other investor: Merck Ventures
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Spain Sanifit Therapeutics
64%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: Ysios Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
United Kingdom ReViral
64%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: Novo A/S, OrbiMed Advisors
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark MinervaX
56%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Seed Capital, Sunstone Life Science Ventures, Novo Seeds
  • Total raised in a similar range: 10M+ USD
Denmark Antag Therapeutics
56%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Minim one investor from outside Scandinavia: Yes
Norway CardioMech
55%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Hadean Ventures
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Acarix
55%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Seed Capital, Sunstone Life Science Ventures, Seventure Partners
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Gesynta Pharma
55%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Hadean Ventures
  • At least one other investor: Novo A/S
  • Total raised in a similar range: 10M+ USD
Denmark Reapplix
55%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Seed Capital, Novo Seeds
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden OxThera
55%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden AMRA
55%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark IO Biotech
55%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • At least one other investor: Novo A/S
  • Total raised in a similar range: 10M+ USD
Iceland Alvotech
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes